H.CheahC
The US Food & Drug Administration (FDA) has approved Wegovy, along with diet and exercise, for two indications (specific uses), as follows: To reduce excess body weight and maintain weight reduction long term in people ages 12 and older with obesity and in people with overweight and have at least one weight-related condition, such as high blood pressure
In 2025, intranasal formulations are also available in the U.S
S.MilutinoviM.BrankoviS.Mihajilov-KrstevT.RandjeloviM.MiladinoviB.et al (2024)
With foundational knowledge about diet, nutrition, and exercise, youll feel empowered to make healthier choices in your everyday life
More specifically, PYY is a member of the pancreatic polypeptide-fold (PP-fold) family which also includes NPY and PP and interacts with a family of receptors (mainly Y2R)